Literature DB >> 19772913

Titanium(IV) complexes: cytotoxicity and cellular uptake of titanium(IV) complexes on caco-2 cell line.

Ramón Hernández1, Janet Méndez, José Lamboy, Madeline Torres, Féliz R Román, Enrique Meléndez.   

Abstract

Replacement of the ancillary ligand in titanocene dichloride by amino acids provides titanocene species with high water solubility. As part of our research efforts in the area of titanium-based antitumor agents, we have investigated the cytotoxic activity of Cp(2)TiCl(2) and three water soluble titanocene-amino acid complexes - [Cp(2)Ti(aa)(2)]Cl(2) (aa=L-cysteine, L-methionine, and D-penicillamine) and one water soluble coordination compound, [Ti(4)(maltolato)(8)(micro-O)(4)] on the human colon adenocarcinoma cell line, Caco-2. At pH of 7.4 all titanocene species decompose extensively while [Ti(4)(maltolato)(8)(micro-O)(4)] is stable for over seven days. In terms of cytotoxicity, the [Cp(2)Ti(aa)(2)]Cl(2) and [Ti(4)(maltolato)(8)(micro-O)(4)] complexes exhibited slightly higher toxicity than titanocene dichloride at 24h, but at 72h titanocene dichloride and [Ti(4)(maltolato)(8)(micro-O)(4)] have higher cytotoxic activity. Cellular titanium uptake was quantified at various time intervals to investigate the possible relationship between Ti uptake and cellular toxicity. Results indicated that there was not a clear relationship between Ti uptake and cytotoxicity. A structure-activity relationship is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19772913      PMCID: PMC2814966          DOI: 10.1016/j.tiv.2009.09.010

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  27 in total

1.  Analyses of Titanocenes in the spheroid-based cellular angiogenesis assay.

Authors:  Holger Weber; James Claffey; Megan Hogan; Clara Pampillón; Matthias Tacke
Journal:  Toxicol In Vitro       Date:  2007-09-29       Impact factor: 3.500

2.  Carbonyl-substituted titanocenes: a novel class of cytostatic compounds with high antitumor and antileukemic activity.

Authors:  Andreas Gansäuer; Iris Winkler; Dennis Worgull; Thorsten Lauterbach; Dieter Franke; Anja Selig; Laura Wagner; Aram Prokop
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

Review 3.  Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond.

Authors:  P Artursson; R T Borchardt
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

4.  Antiproliferative activity of Titanocene Y against tumor colony-forming units.

Authors:  Olaf Oberschmidt; Axel R Hanauske; Clara Pampillón; Nigel J Sweeney; Katja Strohfeldt; Matthias Tacke
Journal:  Anticancer Drugs       Date:  2007-03       Impact factor: 2.248

5.  Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer.

Authors:  C V Christodoulou; D R Ferry; D W Fyfe; A Young; J Doran; T M Sheehan; A Eliopoulos; K Hale; J Baumgart; G Sass; D J Kerr
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

6.  Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane.

Authors:  T Schilling; K B Keppler; M E Heim; G Niebch; H Dietzfelbinger; J Rastetter; A R Hanauske
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

7.  Synthesis, Solution and Solid State Structure of Titanium-Maltol Complex.

Authors:  José L Lamboy; Antonio Pasquale; Arnold L Rheingold; Enrique Meléndez
Journal:  Inorganica Chim Acta       Date:  2007-04-20       Impact factor: 2.545

8.  Synthesis, Ti(IV) intake by apotransferrin and cytotoxic properties of functionalized titanocene dichlorides.

Authors:  Li Ming Gao; Ramón Hernández; Jaime Matta; Enrique Meléndez
Journal:  J Biol Inorg Chem       Date:  2007-06-14       Impact factor: 3.358

Review 9.  Titanium complexes in cancer treatment.

Authors:  Enrique Meléndez
Journal:  Crit Rev Oncol Hematol       Date:  2002-06       Impact factor: 6.312

10.  Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.

Authors:  Marize C Valadares; Aline L Ramos; Franz-Josef K Rehmann; Nigel J Sweeney; Katja Strohfeldt; Matthias Tacke; Mary L S Queiroz
Journal:  Eur J Pharmacol       Date:  2006-03-02       Impact factor: 4.432

View more
  6 in total

1.  Host-Guest Interactions between Calixarenes and Cp(2)NbCl(2).

Authors:  Alexis Morales; Alberto Santana; Gerhard Althoff; Enrique Melendez
Journal:  J Organomet Chem       Date:  2011-07-01       Impact factor: 2.369

Review 2.  A ubiquitous metal, difficult to track: towards an understanding of the regulation of titanium(iv) in humans.

Authors:  Sergio A Loza-Rosas; Manoj Saxena; Yamixa Delgado; Kavita Gaur; Mallesh Pandrala; Arthur D Tinoco
Journal:  Metallomics       Date:  2017-04-19       Impact factor: 4.526

3.  Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.

Authors:  Sergio A Loza-Rosas; Alexandra M Vázquez-Salgado; Kennett I Rivero; Lenny J Negrón; Yamixa Delgado; Josué A Benjamín-Rivera; Angel L Vázquez-Maldonado; Timothy B Parks; Charlene Munet-Colón; Arthur D Tinoco
Journal:  Inorg Chem       Date:  2017-06-23       Impact factor: 5.165

4.  Interaction of metallocene dichlorides with apo-human transferrin: A spectroscopic study and cytotoxic activity against human cancer cell lines.

Authors:  Jorge R Güette Fernández; Xiomara Narváez Pita; Enrique Meléndez; Elsie I Parés Matos
Journal:  Int J Mol Biol (Edmond)       Date:  2020-07-31

5.  Cellular Homeostasis and Antioxidant Response in Epithelial HT29 Cells on Titania Nanotube Arrays Surface.

Authors:  Rabiatul Basria Smn Mydin; Srimala Sreekantan; Roshasnorlyza Hazan; Mustafa Fadzil Farid Wajidi; Ishak Mat
Journal:  Oxid Med Cell Longev       Date:  2017-02-28       Impact factor: 6.543

6.  On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapy.

Authors:  Santiago Gómez-Ruiz; Danijela Maksimović-Ivanić; Sanja Mijatović; Goran N Kaluđerović
Journal:  Bioinorg Chem Appl       Date:  2012-07-12       Impact factor: 7.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.